Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
Study designobservational, non-interventional, retrospective, multicenter study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-05-20
Completion Date
2025-12-31
Last Updated
2025-01-29
Healthy Volunteers
No
Conditions
Locations (9)
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Bologna, Italy
Casa Sollievo della Sofferenza - Reparto di Oncoematologia
San Giovanni Rotondo, Foggia, Italy
Azienda Ospedaliera Universitaria- Policlinico di Bari
Bari, Italy
Ospedale Oncologico Armando Businco
Cagliari, Italy
Ospedale Maggiore della Carità
Novara, Italy
Azienda Ospedaliera "Ospedali Riuniti Villa Sofia-Cervello"
Palermo, Italy
CORE IRCCS Arcispedale Santa Maria Nuova
Reggio Emilia, Italy
Azienda Ospedaliera Santa Maria - SC di Oncoematologia
Terni, Italy
ULSS2 - Ospedale Civile Ca' Foncello - UO Ematologia
Treviso, Italy